Literature DB >> 23095984

Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies.

Stuart J Pocock1, Cono A Ariti, John J V McMurray, Aldo Maggioni, Lars Køber, Iain B Squire, Karl Swedberg, Joanna Dobson, Katrina K Poppe, Gillian A Whalley, Rob N Doughty.   

Abstract

AIMS: Using a large international database from multiple cohort studies, the aim is to create a generalizable easily used risk score for mortality in patients with heart failure (HF). METHODS AND
RESULTS: The MAGGIC meta-analysis includes individual data on 39 372 patients with HF, both reduced and preserved left-ventricular ejection fraction (EF), from 30 cohort studies, six of which were clinical trials. 40.2% of patients died during a median follow-up of 2.5 years. Using multivariable piecewise Poisson regression methods with stepwise variable selection, a final model included 13 highly significant independent predictors of mortality in the following order of predictive strength: age, lower EF, NYHA class, serum creatinine, diabetes, not prescribed beta-blocker, lower systolic BP, lower body mass, time since diagnosis, current smoker, chronic obstructive pulmonary disease, male gender, and not prescribed ACE-inhibitor or angiotensin-receptor blockers. In preserved EF, age was more predictive and systolic BP was less predictive of mortality than in reduced EF. Conversion into an easy-to-use integer risk score identified a very marked gradient in risk, with 3-year mortality rates of 10 and 70% in the bottom quintile and top decile of risk, respectively.
CONCLUSION: In patients with HF of both reduced and preserved EF, the influences of readily available predictors of mortality can be quantified in an integer score accessible by an easy-to-use website www.heartfailurerisk.org. The score has the potential for widespread implementation in a clinical setting.

Entities:  

Keywords:  Heart failure; Meta-analysis; Mortality; Prognostic model

Mesh:

Year:  2012        PMID: 23095984     DOI: 10.1093/eurheartj/ehs337

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  240 in total

1.  Fontan-like circulation as a criterion for heart transplantation in arrhythmogenic right ventricular dysplasia.

Authors:  Christiana Schernthaner; Gerhard Poelzl; Bernhard Strohmer; Richard Steinacher; Marcel Granitz; Johann Altenberger
Journal:  Wien Klin Wochenschr       Date:  2014-11-15       Impact factor: 1.704

2.  Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in African-American Patients With Heart Failure.

Authors:  Boback Ziaeian; Gregg C Fonarow; Paul A Heidenreich
Journal:  JACC Heart Fail       Date:  2017-07-12       Impact factor: 12.035

3.  The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data.

Authors:  R Padwal; F A McAlister; J J V McMurray; M R Cowie; M Rich; S Pocock; K Swedberg; A Maggioni; G Gamble; C Ariti; N Earle; G Whalley; K K Poppe; R N Doughty; A Bayes-Genis
Journal:  Int J Obes (Lond)       Date:  2013-10-31       Impact factor: 5.095

4.  In-Hospital and Three-Year Outcomes of Heart Failure Patients in South India: The Trivandrum Heart Failure Registry.

Authors:  Ganapathi Sanjay; Panniyammakal Jeemon; Anubha Agarwal; Sunitha Viswanathan; Madhu Sreedharan; Govindan Vijayaraghavan; Charantharayil Gopalan Bahuleyan; R Biju; Tiny Nair; N Prathapkumar; G Krishnakumar; N Rajalekshmi; Krishnan Suresh; Lawrence P Park; Mark D Huffman; Sivadasanpillai Harikrishnan
Journal:  J Card Fail       Date:  2018-06-07       Impact factor: 5.712

5.  An Appraisal of Biomarker-Based Risk-Scoring Models in Chronic Heart Failure: Which One Is Best?

Authors:  Barbara S Doumouras; Douglas S Lee; Wayne C Levy; Ana C Alba
Journal:  Curr Heart Fail Rep       Date:  2018-02

Review 6.  Field Synopsis of Sex in Clinical Prediction Models for Cardiovascular Disease.

Authors:  Jessica K Paulus; Benjamin S Wessler; Christine Lundquist; Lana L Y Lai; Gowri Raman; Jennifer S Lutz; David M Kent
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2016-02

7.  Phenomapping for novel classification of heart failure with preserved ejection fraction.

Authors:  Sanjiv J Shah; Daniel H Katz; Senthil Selvaraj; Michael A Burke; Clyde W Yancy; Mihai Gheorghiade; Robert O Bonow; Chiang-Ching Huang; Rahul C Deo
Journal:  Circulation       Date:  2014-11-14       Impact factor: 29.690

8.  Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial).

Authors:  Tetz C Lee; Min Qian; Gregory Y H Lip; Marco R Di Tullio; Susan Graham; Douglas L Mann; Koki Nakanishi; John R Teerlink; Ronald S Freudenberger; Ralph L Sacco; J P Mohr; Arthur J Labovitz; Piotr Ponikowski; Dirk J Lok; Conrado Estol; Stefan D Anker; Patrick M Pullicino; Richard Buchsbaum; Bruce Levin; John L P Thompson; Shunichi Homma; Siqin Ye
Journal:  Am J Cardiol       Date:  2018-06-04       Impact factor: 2.778

Review 9.  Critical appraisal of the obesity paradox in cardiovascular disease: how to manage patients with overweight in heart failure?

Authors:  Wolfram Doehner
Journal:  Heart Fail Rev       Date:  2014-09       Impact factor: 4.214

10.  Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure).

Authors:  Mark C Petrie; Pardeep S Jhund; Lilin She; Christopher Adlbrecht; Torsten Doenst; Julio A Panza; James A Hill; Kerry L Lee; Jean L Rouleau; David L Prior; Imtiaz S Ali; Jyotsna Maddury; Krzysztof S Golba; Harvey D White; Peter Carson; Lukasz Chrzanowski; Alexander Romanov; Alan B Miller; Eric J Velazquez
Journal:  Circulation       Date:  2016-08-29       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.